( click to enlarge )Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Nice breakout on good earnings! Fresh exposures may be considered on price weakness, with a stop-loss at $9.56. A close above $12.55 may be used to enhance exposures. There looks to be good upside in VRX, so keep it on your radar the next few days.
( click to enlarge )Bovie Medical Corporation (NYSEMKT:BVX) looks to be turning the corner on the chart after falling steadily over the last few months. Volume is starting to pick up again and there could be a decent short squeeze if it clears the 2.83 level. Worth adding to your watchlist.
( click to enlarge )MYOS RENS Technology Inc (NASDAQ:MYOS) looks to be setting up for an upside move. The stock is in the top of a short-term trading range. If the stock can break Tuesday highs, we should see a strong follow through move. This move would break the trading range and should drive the stock back towards March highs.
( click to enlarge )Proteostasis Therapeutics Inc (NASDAQ:PTI) is poised for a big run off its recent bottom. The daily price chart shows a falling wedge formation, while MACD is rising. I think a dead cat bounce is in the cards.
( click to enlarge )Check Point Software Technologies Ltd. (NASDAQ:CHKP) Setting up nicely for new highs.
( click to enlarge )Ocera Therapeutics Inc (NASDAQ:OCRX) Some big buyers coming into this name in afte-hours. A high volume move through the 1.42 price level would be buyable.
If you want to contact me for advertising opportunities on blog or twitter, then get in touch via email
Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.
Thanks for visiting AC Investor Blog.
AC
